Science 37 is a Los Angeles-based technology-enabled clinical research company. The company has created a new clinical trial operating model - the metasite - that unlocks access so researchers can find the right patients, and patients can find the right trials. Its Network Oriented Research Assistant, NORA, is an accelerated patient-centric mobile research platform that connects everyone safely and securely.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/18/16 | $31,000,000 | Series B |
dRx Capital Lux Capital Redmile Group Sanofi-Genzyme BioVentures | undisclosed |
| 08/20/20 | $40,000,000 | Venture |
Amgen Business Development Glynn Capital GV LifeSci Venture Partners Lux Capital  Mubadala Ventures Novartis PPD Redmile Group Sanofi Ventures | undisclosed |
